Overview

A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary

Status:
Completed
Trial end date:
2012-04-26
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the effect of 6-months of treatment with NPSP558 in reducing requirements for supplemental oral calcium and active vitamin D, while maintaining stable total serum calcium levels in adult subjects with hypoparathyroidism.
Phase:
Phase 3
Details
Lead Sponsor:
Shire